Literature DB >> 24456889

HDL does not influence the polarization of human monocytes toward an alternative phenotype.

Sophie Colin1, Mélanie Fanchon1, Loic Belloy1, Andrea E Bochem2, Corinne Copin1, Bruno Derudas1, Erik S G Stroes2, G Kees Hovingh2, Jan A Kuivenhoven3, Geesje M Dallinga-Thie2, Bart Staels4, Giulia Chinetti-Gbaguidi1.   

Abstract

BACKGROUND: Macrophages are crucial cells in the pathogenesis of atherosclerosis. Macrophages are plastic cells which can switch from a classical pro-inflammatory M1 to an alternative anti-inflammatory M2 macrophage phenotype, depending on the environmental stimuli. Because high-density lipoprotein (HDL) cholesterol levels are inversely correlated to cardiovascular disease and since HDL displays anti-inflammatory properties, we investigated whether HDL can affect alternative macrophage differentiation of primary human monocytes in the presence of interleukin (IL)-4, a M2 macrophage polarization driver, in vitro and ex vivo. METHODS AND
RESULTS: M2 macrophages are highly responsive to HDL stimulation, since the expression of pentraxin 3 (PTX3), a well known HDL target gene, is induced by HDL more strongly in M2 macrophages than in control unpolarized resting macrophages (RM). As expected, the expression of M2 markers, such as Mannose Receptor (MR), CD200 Receptor (CD200R), Coagulation factor XIII A1 (F13A1), IL-1 receptor antagonist (IL-1RA) and IL10, was induced in IL-4 polarized M2 macrophages compared to RM. However, incubation with HDL added in vitro did not modulate the gene expression of M2 macrophage polarization markers. Moreover, monocytes isolated from subjects with genetically low HDL levels, carrying ABCA1 or LCAT mutations, differentiated ex vivo into M2 macrophages without any difference in the alternative macrophage marker expression profile.
CONCLUSIONS: These in vitro and ex vivo results indicate that, contrary to mouse macrophages, HDL does not influence macrophage M2 polarization of human monocyte-derived macrophages. Thus, the anti-inflammatory properties of HDL in humans are probably not related to the enhancement of the M2 macrophage phenotype.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alternative polarization; HDL; Human macrophages; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 24456889     DOI: 10.1016/j.ijcard.2013.12.168

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  DNA Methylation Mediates the Association Between Individual and Neighborhood Social Disadvantage and Cardiovascular Risk Factors.

Authors:  Yi Zhe Wang; Wei Zhao; Farah Ammous; Yanyi Song; Jiacong Du; Lulu Shang; Scott M Ratliff; Kari Moore; Kristen M Kelly; Belinda L Needham; Ana V Diez Roux; Yongmei Liu; Kenneth R Butler; Sharon L R Kardia; Bhramar Mukherjee; Xiang Zhou; Jennifer A Smith
Journal:  Front Cardiovasc Med       Date:  2022-05-19

2.  High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1.

Authors:  Man K S Lee; Xiao-Lei Moore; Yi Fu; Annas Al-Sharea; Dragana Dragoljevic; Manuel A Fernandez-Rojo; Robert Parton; Dmitri Sviridov; Andrew J Murphy; Jaye P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2015-10-30       Impact factor: 8.739

Review 3.  Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression.

Authors:  Michael Peled; Edward A Fisher
Journal:  Front Immunol       Date:  2014-11-12       Impact factor: 7.561

4.  Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.

Authors:  Winde Jorissen; Elien Wouters; Jeroen F Bogie; Tim Vanmierlo; Jean-Paul Noben; Denis Sviridov; Niels Hellings; Veerle Somers; Roland Valcke; Bart Vanwijmeersch; Piet Stinissen; Monique T Mulder; Alan T Remaley; Jerome J A Hendriks
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

Review 5.  M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment.

Authors:  Ying Bi; Jixiang Chen; Feng Hu; Jing Liu; Man Li; Lei Zhao
Journal:  Neural Plast       Date:  2019-02-21       Impact factor: 3.599

6.  The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome.

Authors:  Chen Li; Hualin Fan; Yuanhui Liu; Lihuan Zeng; Pengyuan Chen; Chongyang Duan; Huasheng Liang; Pengcheng He
Journal:  Ann Transl Med       Date:  2021-11

7.  Diabetes-Induced Changes in Macrophage Biology Might Lead to Reduced Risk for Abdominal Aortic Aneurysm Development.

Authors:  Giulia Chinetti; Joseph Carboni; Joseph Murdaca; Claudine Moratal; Brigitte Sibille; Juliette Raffort; Fabien Lareyre; Elixène Jean Baptiste; Réda Hassen-Khodja; Jaap G Neels
Journal:  Metabolites       Date:  2022-01-29

Review 8.  Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis.

Authors:  Joselyn Rojas; Juan Salazar; María Sofía Martínez; Jim Palmar; Jordan Bautista; Mervin Chávez-Castillo; Alexis Gómez; Valmore Bermúdez
Journal:  Scientifica (Cairo)       Date:  2015-09-27

Review 9.  Macrophage-Based Therapies for Atherosclerosis Management.

Authors:  Renyi Peng; Hao Ji; Libo Jin; Sue Lin; Yijiang Huang; Ke Xu; Qinsi Yang; Da Sun; Wei Wu
Journal:  J Immunol Res       Date:  2020-01-29       Impact factor: 4.818

Review 10.  Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins.

Authors:  Athina Trakaki; Gunther Marsche
Journal:  Biomedicines       Date:  2021-05-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.